You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Glutathione: new roles in redox signaling for an old antioxidant
|
|---|---|
| Published in |
Frontiers in Pharmacology, August 2014
|
| DOI | 10.3389/fphar.2014.00196 |
| Pubmed ID | |
| Authors |
Katia Aquilano, Sara Baldelli, Maria R. Ciriolo |
| Abstract |
The physiological roles played by the tripeptide glutathione have greatly advanced over the past decades superimposing the research on free radicals, oxidative stress and, more recently, redox signaling. In particular, GSH is involved in nutrient metabolism, antioxidant defense, and regulation of cellular metabolic functions ranging from gene expression, DNA and protein synthesis to signal transduction, cell proliferation and apoptosis. This review will be focused on the role of GSH in cell signaling by analysing the more recent advancements about its capability to modulate nitroxidative stress, autophagy, and viral infection. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 17% |
| Canada | 1 | 17% |
| Switzerland | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 544 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | <1% |
| Russia | 1 | <1% |
| Switzerland | 1 | <1% |
| Unknown | 539 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 124 | 23% |
| Researcher | 61 | 11% |
| Student > Master | 58 | 11% |
| Student > Bachelor | 54 | 10% |
| Student > Doctoral Student | 43 | 8% |
| Other | 77 | 14% |
| Unknown | 127 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 123 | 23% |
| Agricultural and Biological Sciences | 100 | 18% |
| Medicine and Dentistry | 41 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 28 | 5% |
| Chemistry | 23 | 4% |
| Other | 77 | 14% |
| Unknown | 152 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 September 2023.
All research outputs
#7,389,455
of 25,623,883 outputs
Outputs from Frontiers in Pharmacology
#3,327
of 19,984 outputs
Outputs of similar age
#67,562
of 247,701 outputs
Outputs of similar age from Frontiers in Pharmacology
#12
of 61 outputs
Altmetric has tracked 25,623,883 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 19,984 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,701 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.